Oramed Pharmaceuticals Inc.
ORMP
$2.73
-$0.02-0.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.35% | -35.88% | -26.02% | -12.41% | -18.70% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 116.88% | -10.88% | 24.55% | 140.41% | -28.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.66% | -35.39% | -25.76% | -11.91% | -18.74% |
|
|
|||||
| Total Current Assets | -4.66% | -35.39% | -25.76% | -11.91% | -18.74% |
| Net Property, Plant & Equipment | 18.85% | 14.73% | -29.01% | -29.04% | -28.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3,293.75% | 14,966.67% | 15,233.33% | 0.00% | 0.00% |
| Total Assets | 33.57% | -12.23% | -27.55% | -29.60% | -28.50% |
|
|
|||||
| Total Accounts Payable | -88.79% | -79.47% | -59.83% | 43.19% | 95.04% |
| Total Accrued Expenses | 2,240.00% | -- | 101,300.00% | 6.72% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.52% | 5.60% | -28.74% | -19.10% | -3.19% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.04% | -1.07% | -83.63% | -89.32% | -93.25% |
|
|
|||||
| Total Current Liabilities | 16.04% | -1.07% | -83.63% | -89.32% | -93.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 216.67% | 174.58% | -55.88% | -54.39% | -52.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 179.39% | -8.29% | -50.45% | -0.29% | 0.02% |
| Total Liabilities | 90.01% | 0.40% | -79.84% | -82.78% | -88.44% |
|
|
|||||
| Common Stock & APIC | 0.93% | 0.50% | 0.75% | 0.47% | 0.89% |
| Retained Earnings | 26.35% | -16.46% | -18.10% | -12.10% | 2.61% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 29.94% | -12.73% | -15.50% | -10.72% | 4.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.94% | -12.73% | -15.50% | -10.72% | 4.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.59% | -3.84% | 0.00% | 1.08% | -1.88% |
| Total Equity | 30.10% | -12.81% | -15.58% | -10.77% | 4.92% |
|
|
|||||